Cita APA

M, D. F., MF, S., JM, F., A, V., M, S., M, G., . . . JP, d. (2026). Brief Report: Emphysema as a Prognostic Factor in Patients With Advanced NSCLC With COPD Receiving Immune Checkpoint Inhibitors.

Citación estilo Chicago

M, Di Frisco, et al. Brief Report: Emphysema As a Prognostic Factor in Patients With Advanced NSCLC With COPD Receiving Immune Checkpoint Inhibitors. 2026.

Cita MLA

M, Di Frisco, et al. Brief Report: Emphysema As a Prognostic Factor in Patients With Advanced NSCLC With COPD Receiving Immune Checkpoint Inhibitors. 2026.